let's talk research annual conference - 24th-25th september 2014 (christine mars)
TRANSCRIPT
![Page 1: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/1.jpg)
![Page 2: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/2.jpg)
The SACRED study was supported by an unrestricted educational grant from Cook Medical
The funder played no part in study design
and was not involved in the analysis or
presentation of results
![Page 3: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/3.jpg)
• Diagnostics • Interventions
![Page 4: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/4.jpg)
Transradial access, growing popularity:
• Reduced access site related bleeding
• Reduced procedural costs
• Patient preference
Challenges include:
• Radial artery spasm
• Radial artery occlusion
![Page 5: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/5.jpg)
Hydrophilic sheaths widely used, associated with::
Radial granuloma
• Reported since 2003: incidence 1.6% - 6.0%
•Observed with previous generation of Cook sheaths
• Peak onset 2-3 weeks post procedure
• Resolution with conservative management
Histology
• Foreign body presence – dislodged sheath coating
![Page 6: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/6.jpg)
• Observation of routine practice using…
• The current generation Cook hydrophilic sheath
• Examining:
• Safety
• Efficacy
• Subsequent incidence of cutaneous reaction
![Page 7: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/7.jpg)
• Observation of routine practice using…
• The current generation Cook hydrophilic sheath
• Examining:
• Safety
• Efficacy
• Subsequent incidence of cutaneous reaction
SACRED:
Systematic Assessment of the Cook®
Radial shEath Device
![Page 8: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/8.jpg)
• Nurse led prospective, single-centre registry study
• Recruiting consecutive eligible patients
• Primary outcome measure
• Incidence of cutaneous granuloma at 28 days
• Secondary outcome measures
• Procedural success rate with the study sheath
• Radial-related intra-arterial vasodilator use
•Access site complications during index admission
![Page 9: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/9.jpg)
• In our centre, a sample size of 400 would be:
• Practical
• Achievable, and…
• Provide reasonable precision for the reported result
Sample size Event rate 95% Confidence Interval Width
400 0.25% 0% - 0.74% ±0.37%
400 4% 2.08% - 5.92% ±1.92%
400 6% 3.67% - 8.33% ±2.33%
![Page 10: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/10.jpg)
October 2013 - January 2014: 54 working days
Total eligible patients 460
Consented patients 432
No radial attempt in the cath lab 6
Radial access attempts: patients 426
Radial access attempts: sites 446
Full or partial sheath insertions 433
Lost to follow-up: (4 patients with 4 single radial sites) 4
Sites analysed for primary outcome measure 429
![Page 11: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/11.jpg)
October 2013 - January 2014: 54 working days
Total eligible patients 460
Consented patients 432
No radial attempt in the cath lab 6
Radial access attempts: patients 426
Radial access attempts: sites 446
Full or partial sheath insertions 433
Lost to follow-up: (4 patients with 4 single radial sites) 4
Sites analysed for primary outcome measure 429
![Page 12: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/12.jpg)
October 2013 - January 2014: 54 working days
Total eligible patients 460
Consented patients 432
No radial attempt in the cath lab 6
Radial access attempts: patients 426
Radial access attempts: sites 446
Full or partial sheath insertions 433
Lost to follow-up: (4 patients with 4 single radial sites) 4
Sites analysed for primary outcome measure 429
![Page 13: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/13.jpg)
October 2013 - January 2014: 54 working days
Total eligible patients 460
Consented patients 432
No radial attempt in the cath lab 6
Radial access attempts: patients 426
Radial access attempts: sites 446
Full or partial sheath insertions 433
Lost to follow-up: (4 patients with 4 single radial sites) 4
Sites analysed for primary outcome measure 429
![Page 14: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/14.jpg)
October 2013 - January 2014: 54 working days
Total eligible patients 460
Consented patients 432
No radial attempt in the cath lab 6
Radial access attempts: patients 426
Radial access attempts: sites 446
Full or partial sheath insertions 433
Lost to follow-up: (4 patients with 4 single radial sites) 4
Sites analysed for primary outcome measure 429
![Page 15: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/15.jpg)
Female (%) 31.2
Diabetes Mellitus (%) 19.7
Hypertension (%) 53.4
Hyperlipidaemia (%) 57.3
Current smoker (%) 24.9
Age, years - mean (SD) 63.9 (10.7)
BMI, kg/m² - mean (SD) 28.7 (5.2)
Wrist circ., cm - mean (SD) 17.6 (1.6)
![Page 16: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/16.jpg)
Durations, minutes Median IQR
Procedure 35 22, 53
Sheath in-situ 30 17, 45
Compression device 250 213, 294
Sheath diameter (%) Sheath length (%)
5 French 91/433 (21.0)
13 cm 6/433 (1.4)
6 French 338/433 (78.1)
23 cm 427/433 (98.6)
![Page 17: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/17.jpg)
Radial access sites prepared n = 446
Success n %
Successful cannulations with study sheath 427 95.7
Procedural completion via any radial 421 94.4
Procedural completion via first lateralisation 408 91.5
![Page 18: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/18.jpg)
Radial access sites prepared n = 446
Success n %
Successful cannulations with study sheath 427 95.7
Procedural completion via any radial 421 94.4
Procedural completion via first lateralisation 408 91.5
Failure
Unsuccessful radial attempts 19 4.3
Completed via contra-lateral radial 13 2.9
Completed femorally 6 1.3
Radial sheath insertion, femoral completion 2 0.4
![Page 19: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/19.jpg)
• Not used routinely by 9/12 radial operators
Radial access sites instrumented 433 %
Given by a routine-use operator 70 16.2
No routine administration of vasodilator 363 83.8
Given in response to radial artery spasm 13/363 3.6
![Page 20: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/20.jpg)
Vascular complications
33/446 (7.4%)
Managed by nurses
20 (60.6%)
Required medical review
13 (39.4%)
Required surgical review
0
Required transfusion 0
Unplanned night in hospital 3 (0.7%)
† Independent of haematoma or ecchymosis
Haematoma ≤3cm 9
Haematoma >3cm 16
Ecchymosis >4cm 7
Arm discomfort 1 †
![Page 21: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/21.jpg)
Radial artery occlusion detected by plethysmography:
Incidence: 15/412 3.6%
95% Confidence Interval 1.83% - 5.44.
![Page 22: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/22.jpg)
Radial artery occlusion detected by plethysmography:
Incidence: 15/412 3.6%
Total not anticoagulated 31/412 7.5%
Anticoagulation given No anticoagulation given p Value
11/381
2.9%
4/31
12.9% 0.02
![Page 23: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/23.jpg)
No other significant factors identified
Patent Occluded p Value
Age - years, mean 63.82 71.53 0.007
Weight - kg, mean 84.39 70.82 0.002
BMI - kg/m², mean 28.85 25.58 0.011
![Page 24: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/24.jpg)
Observed in a single patient:
Day 26
![Page 25: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/25.jpg)
Observed in a single patient:
Day 26
Day 57
![Page 26: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/26.jpg)
Observed in a single patient:
Day 26 Day 57 Day 110
![Page 27: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/27.jpg)
• Incidence: 1/429 0.23%
95% Confidence Interval
Conventional method 0% - 0.68%
![Page 28: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/28.jpg)
• Incidence: 1/429 0.23%
95% Confidence Interval
Conventional method 0% - 0.68%
Exact method 0.01% - 1.29%
![Page 29: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/29.jpg)
• A single incidence 1/429 (0.23%) of a self-limiting skin reaction
![Page 30: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/30.jpg)
• A single incidence 1/429 (0.23%) of a self-limiting skin reaction
• Access:
• Failure rate of 19/446 (4.3%) consistent with other studies
• Predominant non-routine use of intra-arterial vasodilators
![Page 31: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/31.jpg)
• A single incidence 1/429 (0.23%) of a self-limiting skin reaction
• Access:
• Failure rate of 19/446 (4.3%) consistent with other studies
• Predominant non-routine use of intra-arterial vasodilators
• Radial access site complications:
• Mostly managed by nursing teams
• No surgical review or intervention required
• Few requiring overnight stay for primary radial reason
![Page 32: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/32.jpg)
• A single incidence 1/429 (0.23%) of a self-limiting skin reaction
• Access:
• Failure rate of 19/446 (4.3%) consistent with other studies
• Predominant non-routine use of intra-arterial vasodilators
• Radial access site complications:
• Mostly managed by nursing teams
• No surgical review or intervention required
• Few requiring overnight stay for primary radial reason
• Radial artery occlusion:
• Detected in 15/412 (3.6%) sheath instrumented sites
• Associated with failure to anticoagulate, and…
• Older age and lower body weight
![Page 33: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/33.jpg)
• Kate Cullen RN
• Ian Kemp RN
• Carla Livesey RN
• Dr Rod Stables DM
![Page 34: Let's Talk Research Annual Conference - 24th-25th September 2014 (Christine Mars)](https://reader034.vdocuments.us/reader034/viewer/2022042818/55c0addfbb61eb76248b472b/html5/thumbnails/34.jpg)
Thank you